Source: Biospectrum Asia

PolyPlus: Polyplus Builds on Research and Commercial mRNA Support Portfolio with in vivo-jetRNA+ Transfection Reagent

Polyplus Builds on Research and Commercial mRNA Support Portfolio with in vivo-jetRNA®+ Transfection Reagent

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Steven J. Visco's photo - CEO of PolyPlus

CEO

Steven J. Visco

CEO Approval Rating

90/100